Blueprint Medicines hits record high on Sanofi's $9 bln buyout offer

Blueprint Medicines

02/06/2025 15:33

Updates

** Blueprint Medicines BPMC.O jumps 26.5% to record high of $128.15

** Stock set for its best day on record, if gains hold

** French drugmaker Sanofi SASY.PA to buy Blueprint for more than $9 billion

** Sanofi paying $129/share in cash for Blueprint, a 27% premium to last close

** Brokerage Leerink Partners says the deal is "positive for the sector"

 ** Brokerage Guggenheim says it viewed BPMC as one of its "top strategic M&A ideas of 2025"

** Deal's equity value ~$9.1 billion, with potential to increase to $9.5 billion, including contingent value rights

** Acquisition expected to be finalized in Q3 2025

** BPMC up 16.2% this year, as of last close

(Reporting by Sriparna Roy and Kamal Choudhury in Bengaluru)

((Sriparna.Roy@thomsonreuters.com;))